Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial.

INTRODUCTION:Rupatadine is a marketed second generation antihistamine, with anti-PAF activity, indicated for symptomatic treatment of allergic rhinitis and urticaria. This study was conducted to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of rupatadine in healt...

Full description

Bibliographic Details
Main Authors:	Jörg Täubel, Georg Ferber, Sara Fernandes, Ulrike Lorch, Eva Santamaría, Iñaki Izquierdo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5025135?pdf=render

Similar Items

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
by: Antonio Valero, et al.
Published: (2020-04-01)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
by: Joaquim Mullol, et al.
Published: (2019-10-01)

The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study
by: Georg Ferber, et al.
Published: (2015-01-01)

Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children.
by: Eva Santamaría, et al.
Published: (2017-01-01)

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity.
by: Jörg Täubel, et al.
Published: (2015-01-01)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
by: Marmouz F, et al.
Published: (2015-12-01)

Rupatadine
by: Manpreet Kaur, et al.
Published: (2013-06-01)

Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial
by: Kimihiro Okubo, et al.
Published: (2019-04-01)

Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers
by: Jörg Täubel, et al.
Published: (2021-03-01)

Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multicenter, placebo-controlled clinical trial
by: Michihiro Hide, et al.
Published: (2019-01-01)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
by: Lukat KF, et al.
Published: (2013-02-01)

Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial
by: Michihiro Hide, et al.
Published: (2019-10-01)

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
by: Santamaría E, et al.
Published: (2018-09-01)

The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
by: A. A. Kubanov, et al.
Published: (2017-08-01)

Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents.
by: Xiao-xi Lv, et al.
Published: (2013-01-01)

Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
by: Simon Coates, et al.
Published: (2020-03-01)

Utilization of Ethylcellulose Microparticles with Rupatadine Fumarate in Designing Orodispersible Minitablets with Taste Masking Effect
by: Katarzyna Wasilewska, et al.
Published: (2020-06-01)

Intravenous and oral omeprazole: why 40 mg is equivalent to 20 mg?
by: Ana de Lorenzo-Pinto, et al.

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
by: Eileen Deuster, et al.
Published: (2021-09-01)

Pharmacokinetics and Pharmacodynamics during Treatment with the Omeprazole 20 mg Enteric-Coated Tablet and 20 mg Capsule in Asymptomatic Duodenal Ulcer Patients
by: ABR Thomson, et al.
Published: (1997-01-01)

Development and validation of a dissolution test with reversed-phase liquid chromatography analysis for rupatadine in tablet dosage forms
by: Sérgio Luiz Dalmora, et al.
Published: (2010-01-01)

Boosting Akt Pathway by Rupatadine Modulates Th17/Tregs Balance for Attenuation of Isoproterenol-Induced Heart Failure in Rats
by: Lamiaa A. Ahmed, et al.
Published: (2021-04-01)

The System of Ideological Training of Japanese Soldiers in the 30-40s of the 20th Сentury
by: A Dmitrievich Evdokimov
Published: (2011-09-01)

Bronchodilator Efficacy of Single Doses of Indacaterol in Japanese Patients with COPD: A Randomised, Double-Blind, Placebo-Controlled Trial
by: Motokazu Kato, et al.
Published: (2010-01-01)

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
by: Kim D, et al.
Published: (2019-09-01)

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
by: Ana-María Lacosta, et al.
Published: (2018-01-01)

Ethics of placebo use in randomised studies: primer for physiotherapists
by: N. T. Amusat
Published: (2006-01-01)

The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma
by: Steve Goodacre, et al.
Published: (2014-04-01)

Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial
by: Ganesh N Dakhale, et al.
Published: (2016-01-01)

Ethylcellulose in Organic Solution or Aqueous Dispersion Form in Designing Taste-Masked Microparticles by the Spray Drying Technique with a Model Bitter Drug: Rupatadine Fumarate
by: Katarzyna Wasilewska, et al.
Published: (2019-03-01)

Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers.
by: Zhu Luo, et al.
Published: (2016-01-01)

Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
by: Yuko Asai, et al.
Published: (2018-12-01)

Suicide attempts in clinical trials with paroxetine randomised against placebo
by: Gaasemyr Jorund, et al.
Published: (2005-08-01)

A randomised placebo controlled trial of valdecoxib in the treatment of endometriosis
by: Carpenter, Tyrone Thomas
Published: (2005)

A comparison on the effect of 20mg Doxycycline versus placebo in the treatment of chronic periodontitis following scaling and root planning (SRP)
by: Khoshkhoonejad AK., et al.
Published: (2004-06-01)

Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study
by: Khalid Al Sulaiman, et al.
Published: (2020-08-01)

Pharmacokinetic properties of Privigen® in Japanese patients with primary immunodeficiency
by: Tomohiro Morio, et al.
Published: (2019-10-01)

Comparative pharmacokinetics of maxacalcitol in healthy Taiwanese and Japanese subjects
by: Ming-Che Liu, et al.
Published: (2020-03-01)

Intra-articular hyaluronan (Synvisc®, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised, placebo controlled trial
by: Handley Christopher J, et al.
Published: (2011-05-01)

IDENTIFICATION OF PLACEBO RESPONSIVE PARTICIPANTS IN 40KM LABORATORY CYCLING PERFORMANCE
by: Christopher J. Beedie, et al.
Published: (2008-03-01)